Invention Grant
- Patent Title: Rationally designed antibodies
- Patent Title (中): 合理设计的抗体
-
Application No.: US12321828Application Date: 2009-01-26
-
Publication No.: US08771932B2Publication Date: 2014-07-08
- Inventor: Katherine S. Bowdish , Mark Renshaw , Shana Frederickson
- Applicant: Katherine S. Bowdish , Mark Renshaw , Shana Frederickson
- Applicant Address: US CT Cheshire
- Assignee: Alexion Pharmaceuticals, Inc.
- Current Assignee: Alexion Pharmaceuticals, Inc.
- Current Assignee Address: US CT Cheshire
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Main IPC: A61K35/14
- IPC: A61K35/14 ; C07K16/00 ; C07K7/00

Abstract:
Antibodies or fragments thereof having CDR regions replaced or fused with biologically active peptides are described. Flanking sequences may optionally be attached at one or both the carboxy-terminal and amino-terminal ends of the peptide in covalent association with adjacent framework regions. Compositions containing such antibodies or fragments thereof are useful in therapeutic and diagnostic modalities.
Public/Granted literature
- US20100041012A1 Rationally designed antibodies Public/Granted day:2010-02-18
Information query
IPC分类: